Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to 0.48.

  • Integra Lifesciences Holdings' Debt Ratio rose 1430.4% to 0.48 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48, marking a year-over-year increase of 1430.4%. This contributed to the annual value of 0.41 for FY2024, which is 8521.68% up from last year.
  • Per Integra Lifesciences Holdings' latest filing, its Debt Ratio stood at 0.48 for Q3 2025, which was up 1430.4% from 0.46 recorded in Q2 2025.
  • Integra Lifesciences Holdings' 5-year Debt Ratio high stood at 0.48 for Q3 2025, and its period low was 0.2 during Q4 2022.
  • Its 5-year average for Debt Ratio is 0.29, with a median of 0.23 in 2021.
  • As far as peak fluctuations go, Integra Lifesciences Holdings' Debt Ratio crashed by 2213.2% in 2021, and later skyrocketed by 8521.68% in 2024.
  • Over the past 5 years, Integra Lifesciences Holdings' Debt Ratio (Quarter) stood at 0.23 in 2021, then fell by 13.72% to 0.2 in 2022, then grew by 12.03% to 0.22 in 2023, then soared by 85.22% to 0.41 in 2024, then increased by 16.49% to 0.48 in 2025.
  • Its last three reported values are 0.48 in Q3 2025, 0.46 for Q2 2025, and 0.42 during Q1 2025.